Showing results (131-140 of 23,509) with videos related to

Sort By:
Pageof 2,351
The Journal of Pharmacology and Experimental Therapeutics|August 7, 2010
The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptorsChao Zheng, Kechun Yang, Qiang Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 4, 2010
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugsMitali Chattopadhyay, Carlos A Velazquez, April Pruski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 8, 2011
Ethanol is a fast channel inhibitor of P2X4 receptorsOlga Ostrovskaya, Liana Asatryan, Letisha Wyatt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2010
Endothelium-dependent vasodilation in human mesenteric artery is primarily mediated by myoendothelial gap junctions intermediate conductance calcium-activated K+ channel and nitric oxidePreet S Chadha, Lu Liu, Matt Rikard-Bell, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 2010
The role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brainSagar Agarwal, Ramola Sane, John R Ohlfest, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2010
Iron-induced cardiac damage: role of apoptosis and deferasirox interventionYeling Wang, Miaozong Wu, Rabaa Al-Rousan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2010
Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptorsBrandon J Henderson, Ryan E Pavlovicz, Jerad D Allen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2010
Role of CD38, a cyclic ADP-ribosylcyclase, in morphine antinociception and toleranceLynn C Hull, Christopher Rabender, Bichoy H Gabra, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2010
The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptorsDoodipala Samba Reddy, Kuihuan Jian
The Journal of Pharmacology and Experimental Therapeutics|May 29, 2010
Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptorKaren Coopman, Yan Huang, Neil Johnston, et al.
Pageof 2,351